Oxalo Therapeutics is developing a novel drug to prevent recurrent kidney stones. Spun out from the University of Chicago, we use breakthrough discoveries from microbiome research to finally address an underlying cause of kidney stones. Every year kidney stones cause 1.3M+ ER visits and $10+ billion of healthcare costs. Most dangerously, they have a recurrence rate of ~70%. By focusing on prevention, we can end the debilitating pain and tremendous economic burden of this chronic disease.
Employees: 11-50
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | MassChalle... | masschalle... |
Mentions in press and media 5
| Date | Title | Description |
| 17.10.2018 | MassChallenge Awards $1.7M in Cash Prizes to Top Startups in Boston and Rhode Island | October 17, 2018, BOSTON – MassChallenge, a global network of zero-equity startup accelerators, tonight awarded $1 million in cash prizes to 15 of the highest-impact startups from the 2018 Boston accelerator and $500,000 to two startups in ... |
| 01.10.2018 | Here’s the Chicago Tech Companies That Raised Money in September | This is our round up of Chicago tech and startup companies that received venture capital investments during the month of September. If we missed one, let us know at [email protected]. To get funding updates in your inbox each day, sign u... |
| 24.09.2018 | UChicago Biotech Startup Gets $2.3M From NIH, Makes MassChallenge Finals | Chicago biotech company Oxalo Therapeutics, which is developing a drug to treat and prevent kidney stones, has made it to the final round of a high-profile startup accelerator competition while also picking up some new funding to grow. Oxal... |
| 19.09.2018 | MassChallenge Names Top 2018 Startups in Boston and Rhode Island | September 19, 2018, BOSTON – MassChallenge, a global network of zero-equity startup accelerators, today announced the top startups from its 2018 Boston and Rhode Island programs, which together accelerated more than 150 startups across indu... |
| 23.05.2018 | Announcing the 2018 MassChallenge Boston Cohort | We’re thrilled to introduce this year’s MassChallenge Boston cohort, which was selected from more than 1,600 applications from around the world, including 11 countries and 16 U.S. states. Representing the top 8% of all applicants, these 128... |